期刊文献+

雄激素受体在前列腺癌发病和治疗中的作用 被引量:4

原文传递
导出
摘要 在前列腺癌(PCa)的发生和发展过程中,雄激素及其受体(AR)起到了重要的作用。AR是一种配体依赖型的反式转录调节蛋白,属类固醇受体,是真核转录因子。它与配体如双氢睾酮(HDT)结合后可以激活多种与细胞增殖凋亡密切相关的蛋白转录,从而维持肿瘤生长。
作者 谢冲 王国民
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第6期1325-1326,共2页 Chinese Journal of Experimental Surgery
基金 国家985三期医学学科建设项目(985IIIYFX0101)
  • 相关文献

参考文献17

  • 1Ryan C J, Tindall DJ. Androgen receptor rediscovered: the new biology and targe- ting the androgen receptor therapeutical- ly. J Clin Oncol,2011,29 :3651-3658.
  • 2Miyamoto I-I, Messing EM, Chang C. An- drogen deprivation therapy for prostate cancer: current status and future pros-pects. Prostate ,2004,61:332-353.
  • 3汪涌,邵晨,张运涛,刘凡,师长宏,保庭毅,杨增悦.雄激素对前列腺癌细胞的双向作用及其机制[J].中华实验外科杂志,2007,24(1):87-88. 被引量:7
  • 4Feldman B J, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer,2001,1:34-45.
  • 5Singh RR, Kumar R. Steroid hormone re- ceptor signaling in tumorigenesis. J Cell Biochem, 2005,96:490-505.
  • 6Chang CS, Kokontis J, Liao ST. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Sci- ence, 1988,240:324-326.
  • 7Kumar R, Johnson BH, Thompson EB. Overview of the structural basis for tran- scription regulation by nuclear hormone receptors. Essays Biochem, 2004,40 : 27- 39.
  • 8Duff J, Davies P, Watt K, et al. Structural dynamics of the human androgen recep- tor: implications for prostate cancer and neurodegenerative disease. Biochem Soc Trans ,2006,34 : 1098-1102.
  • 9Chuu CP, Kokontis JM, Hiipakka RA, et al. Androgens as therapy for androgen re- ceptor-positive castration-resistant prostate cancer. J Biomed Sci,2011,18 :63.
  • 10Pienta K J, Bradley D. Mechanisms under- lying the development of androgen-inde- pendent prostate cancer. Clin Cancer Res ,2006,12 : 1665-1671.

二级参考文献5

共引文献6

同被引文献33

  • 1余凯远,翁志梁,王思齐,余志贤,陈伟,吴秀玲,李澄棣.间歇性与持续性雄激素阻断治疗晚期前列腺癌疗效比较[J].中华泌尿外科杂志,2006,27(11):761-764. 被引量:31
  • 2王国民,陈伟.前列腺癌与肿瘤干细胞研究的意义及前景[J].中华实验外科杂志,2007,24(10):1162-1163. 被引量:7
  • 3Liang G, Salem CE, Yu MC, et al. DNA methylation differences associ- ated with tumor tissues identified by genome scanning analysis [ J ]. Genomics, 1998,53 ( 3 ) :260-268.
  • 4Yah L, Yang X, Davidson NE. Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer[ J]. J Mam- mary Gland Biol Neoplasia ,2001,6 ( 2 ) : 183-192.
  • 5Kim DH, Nelson HH, Wiencke JK, et al. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer[ J]. Oncogene,2001,20(14) : 1765-1770.
  • 6Gonzalez-Fraile MI, Garcfa-Sanz R, Mateos MV, et al. Methylenetetra- hydrofolate reductase genotype does not play a role in multiple myelo- ma pathogenesis [ J ]. Br J Haemato1,2002,117 ( 4 ) : 890-892.
  • 7Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3 a and Dnmt3b are essential for de novo methylation and mammalian de- velopment [ J ]. Cell, 1999,99 ( 3 ) : 247-257.
  • 8Grossmann ME, Huang H, Tindall DJ. Androgen receptor signaling in androgen-refractory prostate cancer [ J ]. J Natl Cancer Inst, 2001,93 (22) : 1687-1697.
  • 9Merson S, Yang ZH, Brewer D, et al. Focal amplification of the andro- gen receptor gene in hormone-naive human prostate cancer [J]. Br J Cancer,2014,110 ( 6 ) : 1655-1662.
  • 10Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a variety of human tissues [ J ]. Mol Cell Endocrinol, 1996,120(1 ) :51-57.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部